&w=3840&q=100)
Premier Explosives shares jump 10% on bagging ₹190-crore export order
Premier Explosives shares jumped 9.6 per cent in trade on Monday, August 4, 2025, logging an intra-day high at ₹468.05 per share on BSE.
At 12:13 PM, Premier Explosives share price was up 4.24 per cent at ₹445.05 per share. In comparison, BSE Sensex was 0.39 per cent higher at 80,914.55.
Why were Premier Explosives shares buzzing in trade?
The buying on the counter came after the company received an export order from an international entity for a total consideration of ₹190.07 crore ($21,750,000).
Under the contract, the company will manufacture and supply defence explosives, to be delivered within a period of two years.
"This is to inform you that our Company, Premier Explosives Limited, has received an export order for a total consideration of $21,750,000 i.e. approx. ₹190.07 crore, for manufacture and supply of Defence Explosives, to be delivered within a period of 2 years," the filing read.
The order was awarded by an international client and will be executed over the next 12 months, according to the exchange filing. The company clarified that neither its promoters nor promoter group companies have any interest in the awarding entity. The name of the international client remains undisclosed.
Premier Explosives Q4 results
The company reported a 44.3 per cent year-on-year decline in standalone net profit to ₹3.7 crore for the quarter ended March 2025, as revenue fell 14.6 per cent to ₹74.08 crore compared to the same period last year. On a sequential basis, the company's net profit plunged 59.7 per cent, while revenue dropped 55.3 per cent over the December 2024 quarter.
About Premier Explosives
Premier Explosives is engaged in the manufacturing of industrial explosives and detonators for mining, infrastructure, industries, defence and space. It also undertakes operation and maintenance (O&M) services of solid propellant plants at the Sriharikota Centre of ISRO and the Solid Fuel Complex at Jagdalpur under the umbrella of DRDO.
The company is a supplier to major missile programs such as Akash, Astra, LRSAM, and others. It produces critical defence components like pyrogen igniters, explosive bolts, and other ammunition products. The company also manufactures bulk and packaged explosives, detonators, and accessories for mining and infrastructure projects.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Deccan Herald
8 minutes ago
- Deccan Herald
Sensex climbs 304 points, Nifty closes above 24,600 as steady US inflation fuels global rally
The 30-share BSE Sensex climbed 304.32 points or 0.38 per cent to settle at 80,539.91. During the day, it jumped 448.15 points or 0.55 per cent to 80,683.74.


Mint
16 minutes ago
- Mint
Max Healthcare Q1 profit up 17 pc at ₹345 cr
New Delhi, Aug 13 (PTI) Max Healthcare Institute on Wednesday said its profit after tax increased 17 per cent year-on-year to ₹ 345 crore for June quarter FY26 on enhanced utilisation of operational beds across the hospital network. The healthcare major reported a profit after tax (PAT) of ₹ 295 crore in the April-June period last year. Gross revenue rose to ₹ 2,574 crore in the quarter from ₹ 2,028 crore in the year-ago period, Max Healthcare said in a statement. Net debt at June-end stood at ₹ 1,755 crore as compared with ₹ 1,576 crore on March 31, 2025. The company said its board has approved execution of an agreement to lease a built-to-suit 130-bed hospital in Dehradun. The proposed facility will be located near the company's existing 220-bed hospital, which is operational since 2012. Scheduled for commissioning in 2028, the new hospital will, among other specialties, focus on advanced oncology services, including radiation therapy, it said. Besides, Jaypee Healthcare Ltd, a wholly-owned subsidiary, has executed a binding term sheet to divest Chitta (Bulandshahr) and Anoopshahr hospitals to Manush Aushadi and Anusandan Ltd for ₹ 40 crore, subject to working capital adjustment at closing. This move is in line with the company's strategy to concentrate on super-specialty care in larger cities, it said. "Our sustained growth is a reflection of our strategy and execution capabilities," Max Healthcare Institute Chairman and Managing Director Abhay Soi said. The commissioning of 160-bed brownfield tower at Max Mohali, along with additional brownfield capacities coming online at Max Smart and Nanavati-Max shortly, will significantly enhance clinical and financial performance of the network, he added. "In parallel, we are scaling up our clinical and support teams, while optimizing our service mix to ensure rapid and effective utilisation of the new capacities," Soi stated. Shares of the company were trading 0.24 per cent up at ₹ 1,265 apiece on BSE.


Mint
17 minutes ago
- Mint
Star Imaging IPO allotment date likely today. Latest GMP, steps to check share allotment status online of SME IPO
Star Imaging IPO Allotment: The initial public offering (IPO) of healthcare company Star Imaging & Path Lab Ltd ended with a decent subscription. As the bidding period has closed, focus shifts towards Star Imaging IPO allotment date. The public issue was open from August 8 to August 12. Star Imaging IPO allotment date is likely today, 13 August 2025, and the IPO listing date is August 18. Star Imaging IPO is an SME IPO and the equity shares of the company will be listed on BSE SME. The company will finalise the Star Imaging IPO allotment status soon. As soon as the basis of share allotment is fixed, the company will then credit the equity shares into the demat accounts of eligible allotment holders on August 14 and initiate refunds to unsuccessful bidders on the same day. Investors can check Star Imaging IPO allotment status online through the websites of BSE and IPO registrar. Kfin Technologies is the Star Imaging IPO registrar. In order to do Star Imaging IPO allotment status online check, investors must follow a few simple steps mentioned below: Step 2] Select 'Equity' in the Issue Type Step 3] Choose 'Star Imaging & Path Lab Limited' in the Issue Name dropdown menu Step 4] Enter either Application No. or PAN Step 5] Verify by ticking on 'I am not robot' and click on 'Search' Your Star Imaging IPO allotment status will be displayed on the screen. Step 1] Visit IPO registrar's website on this link - Step 2] Choose 'Star Imaging & Path Lab Limited' in the Select IPO dropdown menu Step 3] Select either Application No, Demat Account, or PAN Step 4] Enter the details as per the option selected Step 5] Enter the Captcha code and click on Submit Your Star Imaging IPO allotment status will be displayed on the screen. Star Imaging shares are showing a muted trend in the unlisted market with a little grey market premium (GMP). According to market experts, Star Imaging IPO GMP today is ₹ 3 per share. This means in the grey market, Star Imaging & Path Lab shares are trading higher by ₹ 3 apiece than their issue price. Star Imaging IPO GMP today signals that the estimated listing price of the stock would be ₹ 145 apiece, which is at 2% premium to the IPO price of ₹ 142 per share. The bidding for the SME IPO opened on August 8, and closed on August 12. Star Imaging IPO allotment date is likely today, August 13, and the IPO listing date is August 18. Star Imaging shares will be listed on BSE SME. The company raised ₹ 69.47 crore from the book-building issue which was a combination of fresh issue of 39 lakh equity shares aggregating to ₹ 55.66 crore and offer for sale of 10 lakh shares worth ₹ 13.80 crore. Star Imaging IPO price band was set at ₹ 135 to ₹ 142 per share. Star Imaging IPO was subscribed 5.67 times in total. The retail segment was subscribed 2.32 times, and the Qualified Institutional Bidders (QIB) category was booked 12.85 times. The Non-Institutional Investors (NII) segment received 4.38 times subscription. Share India Capital Services Pvt. Ltd. is the book running lead manager and Kfin Technologies is the Star Imaging IPO registrar.